| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1969000 | Clinical Biochemistry | 2011 | 9 Pages |
Abstract
Cardiac arrest often represents the first expression of an underlying cardiac disease. Despite advances in neurocritical care, the neurological assessment of cardiac arrest patients relies on clinical, instrumental and biochemical parameters. The clinical significance of S-100 calcium binding protein B (S-100B) has substantially increased throughout several areas of clinical neuroscience, but reliable evidences attest it can be used as a reliable and early predictor of poor physiological and cognitive neurological outcomes after cardiac arrest.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Giuseppe Lippi, Rosalia Aloe, Filippo Numeroso, Gianfranco Cervellin,
